AAO News
The latest clinical breakthroughs, practice management updates, and national advocacy alerts directly from the American Academy of Ophthalmology.
Allergan licenses dry eye drug tavilermide
Allergan announced it will develop and commercialize dry eye drug tavilermide through an exclusive licensing agreement with Mimetogen Pharmaceuticals.
Powered by Versicherungsvergleich

West Virginia Academy of Eye Physicians and Surgeons — advancing quality eye care through education, advocacy, and community awareness.
About
Resources
Advocacy

























